Clinical trial
A Non-interventional Study of Patient Medication Adherence and Treatment Effectiveness Among New Users of Linagliptin and Acarbose in the Real-world Clinical Setting in China
NCT04180813 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Non-interventional Study of Patient Medication Adherence and Treatment Effectiveness Among New Users of Linagliptin and Acarbose in the Real-world Clinical Setting in China
- Lead sponsor
- Boehringer Ingelheim
- Phase
- Observational
- Overall status
- Terminated
- Start date
- March 4, 2020
- Completion date
- July 11, 2021
- Enrollment
- 85 (actual)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.